A number of studies have previously suggested that Brg1 facilitates trans-activation of Wnt target genes by activated β-catenin in cancer cell lines [12], [13], zebrafish [31] and during mammalian vascular development [32]. The gene discussed is SMARCA4; the disease is cancer.